Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Betoptic |
| Active Ingredient: | Betaxolol hydrochloride 0.56% equivalent to betaxolol 5mg/mL |
| Dosage Form: | Eye drops, solution |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturers: | Alcon Laboratories Inc, Texas, United States of America Alcon Couvreur NV, Puurs, Belgium |
| Product: | DuoTrav |
| Active Ingredients: | Timolol maleate 6.8mg/mL equivalent to timolol 5.0 mg/mL Travoprost 40mcg/mL |
| Dosage Form: | Eye drops, solution |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturers: | Alcon Laboratories Inc, Texas, United States of America Alcon Couvreur NV, Puurs, Belgium Alcon Singapore Manufacturing Pte Limited, Singapore, Singapore |
Dated this 20th day of April 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).